
Approximately 30% of breast carcinomas lack ER expression. Presumably, these breast cancers become estrogen independent through genetic alterations that bypass the requirement for ER-dependent stimulation of cell proliferation. As such estrogen receptor is a key regulator of proliferation and differentiation in mammary epithelia and represents a crucial prognostic indicator and therapeutic target in breast cancer. Mechanistically, estrogen receptor induces changes in gene expression through direct gene activation of a number of genes (cathepsin D, HSP27 (heat shock protein 27,000 kDa, aldolase A, dehydrogenase, alpha-tubulin, and glyceraldehyde-3-phosphat, Pdzk1, Greb ets) and also through the biological functions of target loci. The product of human MTA3 has been identified as an estrogen-dependent component of the Mi-2/NuRD transcriptional corepressor in breast epithelial cells and demonstrate that MTA3 constitutes a key component of an estrogen-dependent pathway regulating growth and differentiation. The absence of estrogen receptor or of MTA3 leads to aberrant expression of the transcriptional repressor Snail, a master regulator of epithelial to mesenchymal transitions. Aberrant Snail expression results in loss of expression of the cell adhesion molecule E-cadherin, an event associated with changes in epithelial architecture and invasive growth. MTA3 is the mechanistic link between estrogen receptor status and invasive growth of breast cancers.
Contributor: Kosi Gramatikoff, PhD
REFERENCES: Bieche I et al. Identification of CGA as a novel estrogen receptor-responsive gene in breast cancer: an outstanding candidate marker to predict the response to endocrine therapy.Cancer Res. 2001 Feb 15;61(4):1652-8. PMID: 11245479 Fujita N et al. MTA3, a Mi-2/NuRD complex subunit, regulates an invasive growth pathway in breast cancer.Cell. 2003 Apr 18;113(2):207-19. PMID: 12705869 Ghosh MG et al. PDZK1 and GREB1 are estrogen-regulated genes expressed in hormone-responsive breast cancer.Cancer Res. 2000 Nov 15;60(22):6367-75. PMID: 11103799 Kumar R. Another tie that binds the MTA family to breast cancer.Cell. 2003 Apr 18;113(2):142-3. Review. PMID: 12705862 Pethe V, Shekhar PV. Estrogen inducibility of c-Ha-ras transcription in breast cancer cells...J Biol Chem. 1999 Oct 22;274(43):30969-78. PMID: 10521493
万物蓬勃的7月里迎来了2022年ANTOP奖的申报和评审工作。由岛津企业管理(中国)有限公司申报的“3CoinONE全新体验气袋进样器”ANTOP奖进入专家评审阶段。奖项名称:3CoinONE全新体验......
青岛青源峰达太赫兹科技有限公司研发团队在国际顶级期刊《TrendsinBiotechnology》(译名:《生物技术趋势》)在线发表题为“THzmedicalimaging:frominvitroto......
蛋白质作为构成人体组织器官的支架和主要物质,在人体生命活动中起着重要作用。蛋白质的相互作用能产生许多效应,如形成特异底物作用通道、生成新的结合位点、失活、作用底物专一性和动力学变化等,细胞的代谢、信号......
2021年9月9日,无锡臻和生物科技有限公司(以下简称“臻和科技”)与美国VyantBio公司签署TissueofOrigin®(以下简称“TOO®”)全球权益和ZL转让协议,全资收购这款唯一获FDA......
2021年7月20日,JournalofCellularPhysiology及JournalofCellularBiochemistry同时撤回了中国学者49篇文章。从2019年开始,Journalo......
安进宣布,美国FDA授予其在研firstinclass单抗bemarituzumab突破性疗法认定,与改良FOLFOX6化疗方案(亚叶酸钙、氟尿嘧啶和奥沙利铂)联用,一线治疗FGFR2b过表达和HER......
2007年,中国科学院金属研究所研究员张志东在英国《哲学杂志》(PhilosophicalMagazine)上发表论文,提出两个猜想,并在猜想基础上推定出三维伊辛模型的精确解。被《哲学杂志》审稿人评价......
磷酸甘油酸突变酶1(PGAM1)通过其代谢活性以及与其他蛋白质(例如α平滑肌肌动蛋白(ACTA2))的相互作用,在癌症代谢和肿瘤进展中起关键作用。变构调节被认为是发现针对PGAM1的高选择性和有效抑制......
2018年12月6日,来自圣迭戈的消息——Illumina公司(纳斯达克股票代码:ILMN)今天宣布推出新型高密度基因分型芯片Infinium™GlobalDiversityArray。这款芯片设计源......
《NatureChemicalBiology》杂志在线版一篇文章介绍,伊利诺斯州立大学JohnA.Gerlt博士率领的研究小组研制出一种新途径,能够确定氨基酸序列已知的蛋白的结构和功能。这是首次利用计......